Skip to main content
Premium Trial:

Request an Annual Quote

Robin Jackman, William Sims, Matthew Fust, Brian Taylor, Alan Barber, Michael Olex, Peter Brocklesby, Peter Wilver, Theo Melas-Kyriazi


Robin Jackman has become vice president for business development of San Diego-based Vical. He joins the company from Sequenom, where he was vice president of corporate development. Jackman holds a PhD in immunology from Harvard University, a master’s degree in medicine from Harvard Medical School, and a BS in biological science from Stanford University.

Perlegen Sciences has hired William Sims as chief financial officer. He comes to the company from Clontech Laboratories, where he was CFO. He replaces Matthew Fust. Sims, who was also CFO for the Palo Alto Medical Foundation, holds an MBA from the Stanford University Graduate School of Business and a bachelor of science in business from Oregon State University.

Brian Taylor has become president of Growing Company Solutions, a North Potomac, Md., consultancy. He was previously director of global strategic marketing for Qiagen.

BioTrove has appointed Alan Barber as chief financial officer, and has also hired Michael Olex as vice president of manufacturing.

Barber comes to BioTrove from Omnisonics Medical Technologies, where he was also CFO. Before that, he held CFO posts at Innovation Chain,, and Medical Foods. Barber nholds a BS in accounting from Florida State University.

Olex joins BioTrove from US Genomics, where he was senior vice president for manufacturing and operations. He holds an MS in electrical engineering from Cleveland State University, an MBA from Case Western Reserve University, and a BS in electrical engineering from the University of Detroit.

Peter Brocklesby has become president of Applied DNA Sciences, the Los Angeles-based security company said. He used to be vice president of marketing for E-Systems, a defense contractor. He also worked as an independent businessman, developing electronics systems for aircraft in a joint venture with defense contractor Pleesey.

Thermo Electron has named Peter Wilver as its new chief financial officer. Wilver, who will take on his new role Oct. 1, is currently vice president of financial operations. Wilver will succeed Theo Melas-Kyriazi, who will leave Thermo to “pursue entrepreneurial opportunities,” Thermo said last week. He will remain with the company until Wilver takes over.

Wilver, 44, was appointed vice president of financial operations in October 2000. From May 1998 to September 2000, he held finance positions at Honeywell International, most recently serving as vice president and CFO of its electronic materials division. Before joining Honeywell, he served in numerous finance roles with Grimes Aerospace and General Electric.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.